IRD

Opus Genetics Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth↓ 1/10
  • Momentum↑ 9/10
Opus Genetics sales and earnings growth
IRD Growth
Low
  • Revenue Y/Y↑ 74.60%
  • EPS Y/Y↓ -72.48%
  • FCF Y/Y↓ -141.78%
Opus Genetics gross and profit margin trends
IRD Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -466.10%
  • ROIC↑ 467.50%
Opus Genetics net debt vs free cash flow
IRD Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1002.0

Opus Genetics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗